C Champions Oncology Inc
C
Uždarymo kaina
SektoriusSveikatos priežiūra
4.83 0.84
Apžvalga
Akcijų kainos pasikeitimas
24 val.
Min
4.74
Max
4.93
Pajamos | 241K -426K |
|---|---|
Pardavimai | 1.4M 15M |
P/E Sektoriaus vid. | 35.118 47.946 |
Pelnas, tenkantis vienai akcijai | -0.03 |
Pelno marža | -2.797 |
Darbuotojai | 214 |
EBITDA | 79K -95K |
Kitas uždarbis | 2026-12-14 |
|---|
Rinkos kapitalizacija | -3.3M 69M |
|---|---|
Ankstesnė atidarymo kaina | 3.99 |
Ankstesnė uždarymo kaina | 4.83 |
Champions Oncology Inc Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Susijusios naujienos
Akcijų palyginimas
Kainos pokytis
Champions Oncology Inc Prognozė
Finansinės naujienos
Pardavimo ir administravimo išlaidos
Veiklos sąnaudos
Ikimokestinis pelnas
Pardavimai
Pardavimo savikaina
Bendrasis pelnas iš pardavimo
Skolų palūkanų išlaidos
EBITDA
Veiklos pelnas
$
Apie bendrovę Champions Oncology Inc
Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.